Fluorescence immunoassays (FIA) accounted for a share of about 11.2% in the overall immunoassays market in 2012. FIA gives the same sensitivity as radioimmunoassay (RIA) and enzyme immunoassays (EIA), but at a lower cost, since the fluorescent dyes are available at lower prices as compared to enzymes and radioisotopes.
The increasing automation of immunoassays, increasing demand for safer and stable reagents, and development of novel markers such as laser-induced fluorescence probes, and fluorescence-activated cell sorters are the recent trends in the global FIA market. Rapid processing time, improved sensitivity than colorimetric measurements, low cost, and flexibility in development into homogenous or heterogeneous assays are the major reasons behind the growth of this segment.
The report ‘Global Fluorescence immunoassays (FIA) Market forecast for 2018’ analyzes the market by three segments, namely instruments, reagents, and applications.
The report also provides an extensive competitive landscaping of companies operating in this market. The key market players under this segment are Abbott Laboratories (Architect ci8200), Bio-Rad Laboratories, Inc (BioPlex 2200), Danaher Corporation (Beckman Coulter-UniCelDxl800), and Siemens Medical Solutions Diagnostics, Inc. (Siemens Immulite 2000).
Segment and country specific company shares, news & deals, mergers and acquisitions, segment specific pipeline products, product approvals, and product recalls of the major companies have been detailed in this report.
Along with the market data, you can also customize MMM assessments that meet your company’s specific needs. Customize to get comprehensive industry standard and deep dive analysis of the following parameters:
- Unmet needs, revenue pockets, and potential areas for expansion
- Comprehensive review of key component providers, assay providers, sole service providers, and complete solution providers
Current and Emerging Products
- Analysis of current and emerging fluorescence immunoassays (FIA) and immunodiagnostic tests
- Review of current instrumentation technologies
- Pricing trend of new high value immunoassay tests
- Usage pattern (in-depth trend analysis) of products (segment wise)
- Product matrix which gives a detailed comparison of product portfolio of each company mapped at country and sub-segment level
- End-user adoption rate analysis of the products (segment wise and country wise)
- Comprehensive coverage of product approvals, pipeline products, and product recalls
Brand/Product Perception Matrix
- Comprehensive study of customers perception and behavior through our inbuilt social connect tool checking the virility and tonality of blogs
- Analysis of overall brand usage and familiarity and brand advocacy distribution (detractor/neutral/familiar)
Alternative Products: Impact analysis
MMM’s healthcare decision making quadrant is an innovative and useful quadrant for vendors who wish to analyze the potential growth markets based on parameters like patient dynamics (patient pool, epidemiology of disease, preference towards surgeries/alternative therapies) and macroeconomic indicators (number of hospitals and orthopedic clinics, reimbursement scenario, diagnosis rate, treatment rate and healthcare expenditure).
1.1 Analyst Insights
1.2 Market Definitions
1.3 Market Segmentation & Aspects Covered
1.4 Research Methodology
2 Executive Summary
3 Market Overview
4 By Applications
4.2 Endocrine disorders
4.3 Cardiovascular Disorders
4.4 Infectious disease
4.5 Auto-immune Diseases
4.6 Blood Disorders
4.7 Bone and Mineral Disorders
4.8 Toxicology Screening
5 By Endusers
5.2 Medical & Diagnostic Laboratories
5.4 Contract Research Organization (CRO)
6 By Types
6.1 Medium Throughput
6.2 Low Throughput
6.3 High Throughput
7 By Geographies
7.4 Rest of World
8 By Companies
8.1 Siemens AG Healthcare
8.2 Johnson & Johnson
8.4 Abbott Laboratories
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
Europe Fluorescence Immunoassays (FIA)
Fluorescence immunoassays (FIA) accounted for a share of about 11.2% of the overall immunoassays market in 2012. The report “European Fluorescence immunoassays (FIA) Market forecast for 2018 “analyzes the market by three segments such as instruments, reagents and applications.
Asia Fluorescence Immunoassays (FIA)
Fluorescence immunoassays (FIA) accounted for a share of about 11.2% of the overall immunoassays market in 2012. The report “Asian Fluorescence immunoassays (FIA) Market forecast for 2018 “analyzes the market by three segments such as instruments, reagents and applications.
North America Fluorescence Immunoassays (FIA)
Fluorescence immunoassays (FIA) accounted for a share of about 11.2% of the overall immunoassays market in 2012. The report “North American Fluorescence immunoassays (FIA) Market forecast for 2018“ analyzes the market by three segments such as instruments, reagents and applications.